STOCKHOLM, May perhaps 28, 2021 /PRNewswire/ — Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX) (“Calliditas”) currently declared that the firm submitted a Advertising and marketing Authorisation Software (MAA) to the European Medications Agency (EMA) for Nefecon, a novel oral formulation targeting down regulation of IgA1 for the cure of […]
Saturday, Apr 20, 2024
Breaking News